Article
Pharmacogenomics of blood lipid regulation.
Pharmacogenomics - 1 May 2018
Legault Marc-André, Tardif Jean-Claude, Dubé Marie-Pierre
Abstract excerpt
Blood lipids are important modifiable risk factors for coronary heart disease and various drugs have been developed to target lipid fractions. Considerable efforts have been made to identify genetic variants that modulate responses to drugs in the hope of optimizing their use. Pharmacogenomics and new biotechnologies now allow for meaningful integration of human genetic findings and therapeutic development for...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
